None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects aged 20 to 64 who have difficulty sleeping normally. 2. Healthy applicants without any physical illnesses. 3. Subjects who have listened to a detailed explanation of the study and have voluntarily signed the informed consent form. 4. Subjects who are able to be followed up during the study period.
Exclusion criteria
Exclusion criteria: 1. Subjects who are pregnant, breastfeeding, or planning to become pregnant within the next six months. 2. Subjects who are continuously taking medications that can affect brain function. 3. Subjects who are receiving medical treatment or taking medication for psychiatric disorders. 4. Subjects who have participated in a similar study within the past month. 5. Subjects who have used cosmetics or medications with the same or similar efficacy on the study area within the month prior to the study. 6. Subjects with chronic debilitating diseases (e.g., asthma, diabetes, hypertension). 7. Subjects who are continuously taking contraceptives, antihistamines, or anti-inflammatory drugs. 8. Subjects who are employees of this clinical research institute. 9. Subjects who are deemed unsuitable for the study by the investigator's judgment.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| subjective sleep quality;sleep latency;sleep duration;sleep efficiency;sleep disturbances;sleeping medication use;daytime dysfunction | — |
Primary
| Measure | Time frame |
|---|---|
| Gamma Oscillations Power Spectral Density;Pittsburgh Sleep Quality Index, PSQI | — |
Countries
Korea, Republic of
Contacts
Korea Biomedical Research Institute